BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25342539)

  • 21. Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update.
    La Rosa S; Marando A; Sessa F; Capella C
    Cancers (Basel); 2012 Jan; 4(1):11-30. PubMed ID: 24213223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Biliary Mixed Adenoneuroendocrine Carcinoma (MANEC): A Short Review.
    Acosta AM; Wiley EL
    Arch Pathol Lab Med; 2016 Oct; 140(10):1157-62. PubMed ID: 27684986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed adenoneuroendocrine carcinoma of the gallbladder, amphicrine type: Case report and review of literature.
    Zhang D; Li P; Szankasi P; Liao X
    Pathol Res Pract; 2020 Jul; 216(7):152997. PubMed ID: 32534704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Mixed Adenoneuroendocrine Carcinoma of the Gallbladder in a 55-Year-Old Female Patient: A Case Report and Review of the Literature.
    Acosta AM; Hamedani FS; Kajdacsy-Balla A; Wiley EL
    Int J Surg Pathol; 2015 Aug; 23(5):414-8. PubMed ID: 25838330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed exocrine-neuroendocrine carcinoma of the nasal cavity: clinico-pathologic and molecular study of a case and review of the literature.
    La Rosa S; Furlan D; Franzi F; Battaglia P; Frattini M; Zanellato E; Marando A; Sahnane N; Turri-Zanoni M; Castelnuovo P; Capella C
    Head Neck Pathol; 2013 Mar; 7(1):76-84. PubMed ID: 22740238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
    Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
    Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut.
    Furlan D; Cerutti R; Genasetti A; Pelosi G; Uccella S; La Rosa S; Capella C
    Lab Invest; 2003 Jul; 83(7):963-71. PubMed ID: 12861036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.
    Fabbri A; Cossa M; Sonzogni A; Bidoli P; Canova S; Cortinovis D; Abbate MI; Calabrese F; Nannini N; Lunardi F; Rossi G; La Rosa S; Capella C; Tamborini E; Perrone F; Busico A; Capone I; Valeri B; Pastorino U; Albini A; Pelosi G
    Virchows Arch; 2017 Jul; 471(1):31-47. PubMed ID: 28451756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal origins.
    Qiu MZ; Chen Q; Zheng DY; Zhao Q; Wu QN; Zhou ZW; Yang LQ; Luo QY; Sun YT; Lai MY; Yuan SS; Wang FH; Luo HY; Wang F; Li YH; Zhang HZ; Xu RH
    Cell Rep; 2023 Jun; 42(6):112576. PubMed ID: 37285266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing.
    Jauhri M; Bhatnagar A; Gupta S; Shokeen Y; Minhas S; Aggarwal S
    Med Oncol; 2016 Oct; 33(10):106. PubMed ID: 27568332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: A systematic review with Bayesian hierarchical survival analysis.
    Grossi U; Bonis A; Carrington EV; Mazzobel E; Santoro GA; Cattaneo L; Centonze G; Gallo G; Kazemi Nava A; Romano M; Di Tanna GL; Zanus G
    Eur J Surg Oncol; 2021 Nov; 47(11):2893-2899. PubMed ID: 34052038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation landscape and intra-tumor heterogeneity of two MANECs of the esophagus revealed by multi-region sequencing.
    Yuan W; Liu Z; Lei W; Sun L; Yang H; Wang Y; Ramdas S; Dong X; Xu R; Cai H; Li JZ; Ke Y
    Oncotarget; 2017 Sep; 8(41):69610-69621. PubMed ID: 29050228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation.
    Hashimoto R; Matsusaka K; Matsumura T; Hayano K; Kato N; Matsubara H; Ikeda JI
    Pathol Int; 2023 Jun; 73(6):261-263. PubMed ID: 37067391
    [No Abstract]   [Full Text] [Related]  

  • 35. P53 Gene Mutation Identified by Next Generation Sequencing in Poorly Differentiated Neuroendocrine Carcinoma of the Nasal Cavity.
    Wasserman JK; AlGhamdi D; de Almeida JR; Stockley TL; Perez-Ordonez B
    Head Neck Pathol; 2019 Sep; 13(3):516-522. PubMed ID: 29845478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed adenoneuroendocrine carcinoma of the urethra.
    Raison N; McGovern U; Hines J; Volanis D
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30902843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed Adenoneuroendocrine Carcinoma of the Gastroesophageal Junction: A Rare Find.
    Ambesh P; Weissbrot J; Ratner S; Sinha A; Patti R; Balderacchi J; Marcelin M; Wolf L; Kamholz S
    J Investig Med High Impact Case Rep; 2017; 5(4):2324709617750180. PubMed ID: 29318164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of TP53 mutations determined by next-generation "deep" sequencing in prognosis of estrogen receptor-positive breast cancer.
    Uji K; Naoi Y; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
    Cancer Lett; 2014 Jan; 342(1):19-26. PubMed ID: 23973262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
    Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
    Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
    Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
    Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.